BAM66435
Vandetanib
Vandetanib (Zactima) is a VEGFR and EGFR antagonist and a tyrosine kinase inhibitor with IC50 of 60, 90, 40 nM for HUVEC proliferation, PC-9 cells and tyrosine kinase activity, respectively.
|
Quantity
Price
25 mg
65.00
100 mg
220.00
250 mg
475.00
|
|
C22H24BrFN4O2
|
443913-73-3
|
98+%
|
MFCD07772346 |
|
BAM66435
Zactima
Vandetanib (Zactima) is a VEGFR and EGFR antagonist and a tyrosine kinase inhibitor with IC50 of 60, 90, 40 nM for HUVEC proliferation, PC-9 cells and tyrosine kinase activity, respectively.
|
Quantity
Price
25 mg
65.00
100 mg
220.00
250 mg
475.00
|
|
C22H24BrFN4O2
|
443913-73-3
|
98+%
|
MFCD07772346 |
|
BAM66435
ZD6474
Vandetanib (Zactima) is a VEGFR and EGFR antagonist and a tyrosine kinase inhibitor with IC50 of 60, 90, 40 nM for HUVEC proliferation, PC-9 cells and tyrosine kinase activity, respectively.
|
Quantity
Price
25 mg
65.00
100 mg
220.00
250 mg
475.00
|
|
C22H24BrFN4O2
|
443913-73-3
|
98+%
|
MFCD07772346 |
|
BAM66436
Midostaurin
PKC 412 is a cell-permeable, reversible inhibitor of several serine/threonine and tyrosine kinases, including conventional PKC isoforms, Syk, Flk-1, Akt, PKA, c-Kit, C-Fgr, c-Src, FLT3, PDFRß, VEGFR1, and VEGFR2 with IC50 values ranging from 80-500 nM.
|
Quantity
Price
1 mg
110.00
|
|
C35H30N4O4
|
120685-11-2
|
99+%
|
MFCD10687105 |
|
BAM66436
PKC-412
PKC 412 is a cell-permeable, reversible inhibitor of several serine/threonine and tyrosine kinases, including conventional PKC isoforms, Syk, Flk-1, Akt, PKA, c-Kit, C-Fgr, c-Src, FLT3, PDFRß, VEGFR1, and VEGFR2 with IC50 values ranging from 80-500 nM.
|
Quantity
Price
1 mg
110.00
|
|
C35H30N4O4
|
120685-11-2
|
99+%
|
MFCD10687105 |
|
|